These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20407775)

  • 21. Identifying cost-effective dynamic policies to control epidemics.
    Yaesoubi R; Cohen T
    Stat Med; 2016 Dec; 35(28):5189-5209. PubMed ID: 27449759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ebola: Impact of hospital's admission policy in an overwhelmed scenario.
    Zahid MH; Kribs CM
    Math Biosci Eng; 2018 Dec; 15(6):1387-1399. PubMed ID: 30418790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal but unequitable prophylactic distribution of vaccine.
    Keeling MJ; Shattock A
    Epidemics; 2012 Jun; 4(2):78-85. PubMed ID: 22664066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Threshold dynamics of a time-delayed SEIRS model with pulse vaccination.
    Bai Z
    Math Biosci; 2015 Nov; 269():178-85. PubMed ID: 26408988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simple Approximations for Epidemics with Exponential and Fixed Infectious Periods.
    Fowler AC; Hollingsworth TD
    Bull Math Biol; 2015 Aug; 77(8):1539-55. PubMed ID: 26337289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal individual strategies for influenza vaccines with imperfect efficacy and durability of protection.
    Salvarani F; Turinici G
    Math Biosci Eng; 2018 Jun; 15(3):629-652. PubMed ID: 30380323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting the cumulative number of cases for the COVID-19 epidemic in China from early data.
    Liu ZH; Magal P; Seydi O; Webb G
    Math Biosci Eng; 2020 Apr; 17(4):3040-3051. PubMed ID: 32987515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability analysis and optimal control of an SIR epidemic model with vaccination.
    Kar TK; Batabyal A
    Biosystems; 2011; 104(2-3):127-35. PubMed ID: 21315798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal control strategies for the transmission risk of COVID-19.
    Lemecha Obsu L; Feyissa Balcha S
    J Biol Dyn; 2020 Dec; 14(1):590-607. PubMed ID: 32696723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resource Allocation for Epidemic Control Across Multiple Sub-populations.
    Dangerfield CE; Vyska M; Gilligan CA
    Bull Math Biol; 2019 Jun; 81(6):1731-1759. PubMed ID: 30809774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal control of pattern formations for an SIR reaction-diffusion epidemic model.
    Chang L; Gao S; Wang Z
    J Theor Biol; 2022 Mar; 536():111003. PubMed ID: 35026213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An epidemic model with a multistage vaccine.
    DeLegge A; Hunzinger K; Khatri R; Munir K
    Bull Math Biol; 2015 Mar; 77(3):499-513. PubMed ID: 25698086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SIS and SIR Epidemic Models Under Virtual Dispersal.
    Bichara D; Kang Y; Castillo-Chavez C; Horan R; Perrings C
    Bull Math Biol; 2015 Nov; 77(11):2004-34. PubMed ID: 26489419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling the transmission dynamics and the impact of the control interventions for the COVID-19 epidemic outbreak.
    Saldaña F; Flores-Arguedas H; Camacho-Gutiérrez JA; Barradas I
    Math Biosci Eng; 2020 Jun; 17(4):4165-4183. PubMed ID: 32987574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Finding optimal vaccination strategies under parameter uncertainty using stochastic programming.
    Tanner MW; Sattenspiel L; Ntaimo L
    Math Biosci; 2008 Oct; 215(2):144-51. PubMed ID: 18700149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal Epidemic Control under Uncertainty: Tradeoffs between Information Collection and Other Actions.
    Flaig J; Houy N
    Med Decis Making; 2023 Apr; 43(3):350-361. PubMed ID: 36843493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamics of an ultra-discrete SIR epidemic model with time delay.
    Sekiguchi M; Ishiwata E; Nakata Y
    Math Biosci Eng; 2018 Jun; 15(3):653-666. PubMed ID: 30380324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of SIR epidemic models with nonlinear incidence rate and treatment.
    Hu Z; Ma W; Ruan S
    Math Biosci; 2012 Jul; 238(1):12-20. PubMed ID: 22516532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An immuno-epidemiological model with waning immunity after infection or vaccination.
    Angelov G; Kovacevic R; Stilianakis NI; Veliov VM
    J Math Biol; 2024 Apr; 88(6):71. PubMed ID: 38668894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal vaccination in a stochastic epidemic model of two non-interacting populations.
    Yuan EC; Alderson DL; Stromberg S; Carlson JM
    PLoS One; 2015; 10(2):e0115826. PubMed ID: 25688857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.